GENDER FEATURES OF INTERACTION HORMONAL ACTIVITY ADIPOSE TISSUE AND PROINFLAMMATORY STATUS IN HYPERTENSION WITH METABOLIC SYNDROME
https://doi.org/10.20538/1682-0363-2014-5-12-19
Abstract
Objective: research gender features of relationship of hormonal activity of adipose tissue and proinflammatory status with essential hypertension (EH) in combination with metabolic syndrome (MS).
Material and methods. Were examined 46 patients with essential hypertension stage (BP < 180/110 mm Hg.) in conjunction with the metabolic syndrome. Along with a complete clinical, laboratory and instrumental examination adopted in specialized cardiological clinic, were defined concentrations in serum leptin, adiponectin, resistin and visfatin and the level of markers of systemic inflammation (C-reactive protein, neopterin and fibrinogen), was assessed the level of spontaneous production of cytokines and active oxygen species and the expression level of CD4, CD8 and CD36 – blood mononuclear leukocytes markers.
Results and conclusions. It was established that the hormonal status of adipose tissue have women with EH combined with MS are characterized by higher levels of leptin and adiponectin in blood serum than in men.
It was established not only a significant role adipokin imbalance in mechanisms of MS and systemic inflammation in these patients category, but also were studied gender characteristics. While for men in the development of the above pathological manifestations hipoadiponektinemia has the most meaning, and for women – hyperleptinemia.About the Authors
I. D. Bespalova
Siberian State Medical University, Tomsk
Russian Federation
Bespalova Inna D.
Russian Federation
Bespalova Inna D.
N. V. Ryazantseva
Siberian State Medical University, Tomsk
Russian Federation
Ryazantseva Natalia V.
Russian Federation
Ryazantseva Natalia V.
V. V. Kalyuzhin
Siberian State Medical University, Tomsk
Russian Federation
Kalyuzhin Vadim V.
Russian Federation
Kalyuzhin Vadim V.
I. A. Osikhov
Siberian State Medical University, Tomsk
Russian Federation
Osikhov Ivan A.
Russian Federation
Osikhov Ivan A.
B. Yu. Murashev
Siberian State Medical University, Tomsk
Russian Federation
Murashev Boris Yu.
Russian Federation
Murashev Boris Yu.
Yu. A. Medyantsev
Municipal Healthcare Institution “Tomsk Central Regional Hospital”, Tomsk
Russian Federation
Medyantsev Yury A.
Russian Federation
Medyantsev Yury A.
V. A. Rudnitsky
Siberian State Medical University, Tomsk
Russian Federation
Rudnitsky Vladislav A.
Russian Federation
Rudnitsky Vladislav A.
References
1. Makolkin V.I. [Metabolic syndrome]. Moscow, Meditsinskoye informatsionnoye agentstvo Publ., 2010. 144 p. (in Russian).
2. Mychka V.B., Zhernakova Yu.V., Chazova I.E. [References of experts of the All-Russia society of cardiologists on diagnostics and treatment of a metabolic syndrome (the second revision)]. Moscow, Doctor. Ru Publ., 2010. 18 p. (in Russian).
3. Mottillo S., Filion K.B., Genest J. et al. Metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J. Am. Coll. Cardiol., 2010, vol. 56, no. 14, pp. 1113-1132.
4. Bespalova I.D., Medyantsev Yu.A., Kalyuzhin V.V. Quality of life in patients with essential hypertension and metabolic syndrome. Arterialnaya gipertenziya — Arterial hypertension, 2012, vol. 18, no. 4, pp. 304-309.
5. Bespalova I.D., Kalyuzhin V.V., Medyantsev Yu. A. Quality of life in patients with coronary heart disease: interrelation with components of metabolic syndrome and markers of systemic inflammation. Bull. sibirskoy meditsini — Bulletin of Siberian medicine, 2012, vol. 11, no. 6, pp. 17-20.
6. Bespalova I.D., Bychkov V.A., Kalyuzhin V.V. et al. Quality of life of hypertensive patients with metabolic syndrome: relationship with markers of inflammation. Bull. Sibirskoy Meditsini — Bulletin of Siberian medicine, 2013, vol. 12, no. 6, pp. 5-12.
7. Bespalova I.D., Kalyuzhin V.V., Ryazantseva N.V. et al. Hyperleptinemia influence on quality of life of hypertensive patients with metabolic syndrome. Arterialnaya gipertenziya — Arterial Hypertension, 2013, vol. 19, no. 5, pp. 428-434.
8. Kalyuzhin V.V., Teplyakov A.T., Ryazantseva N.V., Bespalova I.D. et al. Quality of life in patients with coronary heart disease associated with the metabolic syndrome: results of the factor analysis. Terapevticheskiy archiv — Therapeutic Archives, 2012, no. 12, pp. 18-22.
9. Bespalova I.D., Ryazantseva N.V., Kalyuzhin V.V. et al. Systemic inflammation in the pathogenesis of the metabolic syndrome and its associated diseases. Sibirskiy meditsinskiy zhurnal (Irkutsk) — Siberian Medical Journal, 2013, no. 2, pp. 5-9.
10. Osikhov I.A., Bespalova I.D., Bychkov V.A. et al. Impaired intercellular interactions in the pathogenesis of inflammation of adipose tissue and metabolic syndrome. Bull. sibirskoy meditsini — Bulletin of Siberian Medicine, 2013, vol. 12, no. 6, pp. 144-153.
11. Drapkina O.M., Korneeva O.N., Palatkina L.O. Adipokines and cardiovascular diseases: impact on pathogenesis and therapeutic perspectives. Arterialnaya gipertenziya — Arterial Hypertension, 2011, vol. 17, no. 3, pp. 203-208.
12. Shvarts V. Adipose tissue as an endocrine organ. Problemy endokrinologii — Problems of Endocrinology, 2009, vol. 55, no. 1, pp. 38-44.
13. Chasovskikh N.Yu., Ryazantseva N.V., Kaygorodova E.V. et al. System state of MAP-kinases JNK and p38 in mononuclear blood leukocytes in inflammation. Meditsinskaya immunologiya — Medical Immunology, 2009, vol. 11, no. 6, pp. 515-522.
14. Bespalova I.D. Leptin as an inducer of inflammation and oxidative stress by metabolic syndrome. Bull. sibirskoy meditsini —Bulletin of Siberian medicine, 2014, vol. 13, no. 1, pp. 20-26.
15. Klinicheskie rekomendacii Evropejskogo obshhestva kardiologov [ESC Committee for Practice Guidelines to improve the quality of clinical practice and patient care in Europe]. Moscow, 2008. 186 p.
16. Bekezin V.V. Sagittal abdominal diameter in the diagnosis of visceral obesity in children and adolescents. Russian Journal of Medical and Biological nam. of Acad. I.P. Pavlov, 2004, no. 3-4, pp. 186-188 (in Russian).
17. Sjostrom C.D., Lissner L., Sjostrom L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study Swedish Obese Subjects. Obes. Res., 1997, vol. 5, no. 6, pp. 519-530.
18. Totolyan A.A., Baldueva I.A., Bubnova L.N. Standardization of immunophenotyping of blood and bone marrow. Klinicheskaya laboratornaya diagnostika — Clinical Laboratory Diagnostics, 2002, no. 1, pp. 44-50.
19. Belyaeva O.D., Bazhenova E.A., Berezina A.V. et al. Adiponectin levels, figures of lipid and carbohydrate metabolism in patients with abdominal obesity. Arterialnaya gipertenziya — Arterial Hypertension, 2009, vol. 15, no. 3, pp. 309-313.
20. Laughlin G., Barret-Connor E., May S. Sex-specific determinants of serum adiponectin in older adults: the role endogenous sex hormones. Int. J. Obes., 2007, vol. 31, no. 3, pp. 457-465.
21. Minyaylova N.N., Sundukova E.L., Rovda Yu.I. Hyperleptinemia and its clinical association with the metabolic syndrome, insulin resistance in children and adolescents. Pediatriya — Pediatrics, 2009, vol. 88, no. 6, pp. 6-13.
22. Janeckova R. The Role of Leptin in Human Physiology and Pathophysiology. Physiol. Pes., 2001, vol. 50, pp. 443-459.
23. Salikhova A.F., Farkhutdinova L.M. Immunological features of obesity and their relationship with impaired glucose and lipid metabolism. Meditsinskaya immunologiya — Medical Immunology, 2013, vol. 15, no. 5, pp. 465-470.
24. Baranova A.V. Genetics adipokines: secretory imbalance adipose tissue as the basis of the metabolic syndrome. Genetika — Genetics, 2008, vol. 44, no. 10, pp. 1338-1355.
25. Boyarinova M.A., Rotar’ O.P., Erina A.M. et al. [Gender features of association adipokines with insulin resistance in patients with risk factors]. Materialy Rossiyskogo natsional’nogo kongressa kardiologov “Integratsiya znaniy v kardiologii" [Materials of the Russian National Congress of Cardiology “Integration of knowledge in cardiology”]. Moscow, 2012. P. 82.
Review
For citations:
Bespalova I.D., Ryazantseva N.V., Kalyuzhin V.V., Osikhov I.A., Murashev B.Yu., Medyantsev Yu.A., Rudnitsky V.A. GENDER FEATURES OF INTERACTION HORMONAL ACTIVITY ADIPOSE TISSUE AND PROINFLAMMATORY STATUS IN HYPERTENSION WITH METABOLIC SYNDROME. Bulletin of Siberian Medicine. 2014;13(5):12-19. (In Russ.) https://doi.org/10.20538/1682-0363-2014-5-12-19
Views:
917
Email this article 